Evaluation of the Expression and Functions of the KIR3DL2 Receptor and the Anti-inflammatory Activity of IPH4102 in Blood Samples

Clinical trial NCT03322618 · COMPLETED

Trial details

NCT number: NCT03322618
Sponsor: Assistance Publique Hopitaux De Marseille
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Axial Spondyloarthritis (axSpA)Ankylosing Spondylitis (AS)

Start date: 2017-12-18
Primary completion: 2019-09-17
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.